Inventor · Edinburgh, GB

Jonathan Robert Seckl

14Patents
7h-index
12Co-inventors
59Inventor score

Filing activity: Feb 27, 1998 → May 13, 2016

Most-cited inventions

PatentTitleAreaCited byStatus
US6368816B2 Regulation of intracellular glucocorticoid concentrations Human Necessities 48 Expired
US7122531B2 Regulation of intracellular glucocorticoid concentrations Human Necessities 44 Expired
US7087400B2 Regulation of intracellular glucocorticoid concentrations Human Necessities 44 Expired
US7122532B2 Regulation of intracellular glucocorticoid concentrations Human Necessities 38 Expired
US6946487B2 Regulation of intracellular glucocorticoid concentrations Human Necessities 30 Expired
US7129231B2 Regulation of intracellular glucocorticoid concentrations Human Necessities 30 Expired
US6838253B2 Regulation of intracellular glucocorticoid concentrations Human Necessities 30 Expired
US6420353B1 Use of 7 &agr;-substituted steroid to treat neuropsychiatric, immune or endocrine disorders Human Necessities 6 Expired
US8362008B2 Amido-thiophene compounds and their use as 11-beta-HSD1 inhibitors Chemistry; Metallurgy 5 Active
US8299063B2 Amido-thiophene compounds and their use Chemistry; Metallurgy 5 Active
US8614209B2 Amido-thiophene compounds and their use Chemistry; Metallurgy 3 Active
US8642621B2 (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use Chemistry; Metallurgy 2 Active
US9365564B2 3,3-disubstituted-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (β)-HSD1 Chemistry; Metallurgy 1 Active
US9834549B2 3,3-disubstituted-(8-aza-bicyclo[3.2.1]OCT-8-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (β)-HSD1 Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.